Literature DB >> 33433639

Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations.

Ulrich Schüller1,2,3, Peter Iglauer4, Mario M Dorostkar5,6, Christian Mawrin7, Jochen Herms5,6, Armin Giese5, Markus Glatzel8, Julia E Neumann9.   

Abstract

Entities:  

Year:  2021        PMID： 33433639     DOI： 10.1007/s00401-020-02259-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  6 in total

Review 1.  Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity.

Authors:  Carlos Axel López-Pérez; Xochitl Franco-Mojica; Ricardo Villanueva-Gaona; Alexandra Díaz-Alba; Marco Antonio Rodríguez-Florido; Victor Garcia Navarro
Journal:  J Neurooncol       Date:  2022-05-14       Impact factor: 4.130

Review 2.  H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients.

Authors:  Huy Gia Vuong; Hieu Trong Le; Tam N M Ngo; Kar-Ming Fung; James D Battiste; Rene McNall-Knapp; Ian F Dunn
Journal:  J Neurooncol       Date:  2021-11-18       Impact factor: 4.130

3.  Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas.

Authors:  Huy Gia Vuong; Tam N M Ngo; Hieu Trong Le; Andrew Jea; Maya Hrachova; James Battiste; Rene McNall-Knapp; Ian F Dunn
Journal:  Front Oncol       Date:  2022-03-18       Impact factor: 6.244

4.  Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!

Authors:  Arnault Tauziède-Espariat; Aurore Siegfried; Emmanuelle Uro-Coste; Yvan Nicaise; David Castel; Annick Sevely; Marion Gambart; Sergio Boetto; Lauren Hasty; Alice Métais; Fabrice Chrétien; Joseph Benzakoun; Stéphanie Puget; Jacques Grill; Volodia Dangouloff-Ros; Nathalie Boddaert; Azadeh Ebrahimi; Pascale Varlet
Journal:  Acta Neuropathol Commun       Date:  2022-08-19       Impact factor: 7.578

5.  Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.

Authors:  Anna-Luisa Luger; Sven König; Patrick Felix Samp; Hans Urban; Iris Divé; Michael C Burger; Martin Voss; Kea Franz; Emmanouil Fokas; Katharina Filipski; Melanie-Christin Demes; Albrecht Stenzinger; Felix Sahm; David E Reuss; Patrick N Harter; Sebastian Wagner; Elke Hattingen; Jennifer Wichert; Constantin Lapa; Stefan Fröhling; Joachim P Steinbach; Michael W Ronellenfitsch
Journal:  J Neurooncol       Date:  2022-07-21       Impact factor: 4.506

6.  Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas.

Authors:  Peter Raab; Rouzbeh Banan; Arash Akbarian; Majid Esmaeilzadeh; Madjid Samii; Amir Samii; Helmut Bertalanffy; Ulrich Lehmann; Joachim K Krauss; Heinrich Lanfermann; Christian Hartmann; Roland Brüning
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.